Last week, IBEC welcomed a group of third year E.S.O. students from the Oak House School in Barcelona, who were taking part in the ESCOLAB initiative of the City Council of Barcelona.

IBEC director and head of the Biomaterials for Regenerative Therapies group Josep Planell was quoted as an expert opinion last week in an article in La Vanguardia. The story covered a new chip developed at MIT able to release drugs under the skin while dosage and timing is controlled wirelessly.

This week's 5th Annual Conference of the Biomedical Research Technology Platforms in Barcelona, which IBEC is attending in its capacity as coordinator of the Spanish Nanomedicine Platform (NanoMed Spain), is the subject of an article in Spanish healthcare magazine Redacción Médica today.

The two IBEC-led CIBER-BBN tissue regeneration projects that were earmarked for funding by the EU's ERA-NET EuroNanoMed initiative last year (see http://www.ibecbarcelona.eu/IBEC-News/funding-success-for-two-ibec-projects.html) have both received the national support they need to get started.

The two IBEC-led CIBER-BBN tissue regeneration projects that were earmarked for funding by the EU's ERA-NET EuroNanoMed initiative last year (see http://www.ibecbarcelona.eu/IBEC-News/funding-success-for-two-ibec-projects.html) have both received the national support they need to get started.

IBEC director Josep Planell’s research group has changed its name and is now known as the Biomaterials for Regenerative Therapies group.

Wednesday last week saw the biannual meeting at the institute of the steering committee of the Spanish NanoMedicine Platform (NanoMed Spain), which is coordinated by IBEC.

The Barcelona Science Park (PCB), where IBEC is located, has just launched a new multimedia platform to publicize the activities of the 75 companies and three research institutes working there.

Alícia Casals’ Robotics laboratory was featured on Barcelona Televisió's programme "Connexió" on Tuesday 10th January, where they showed some of the robotic devices that the lab is currently developing.

Much like a kindergarten full of unruly toddlers, the cells that contribute to the body’s crucial processes can’t always be trusted to do what you want or expect them to do. Now IBEC researchers have made an important breakthrough that could contribute to the development of therapies for spinal and neural diseases:  they’ve figured out exactly what it is that makes certain cells misbehave in particular circumstances.